MarketPeel
Insider Trading Intelligence
JG

Jerry B. Gin

VTGN
DIRECTOR · VISTAGEN THERAPEUTICS, INC. · CIK 0000901014
FILING MIX · LIFETIME100%/0%
BUYS
7
SELLS
0
TOTAL VALUE
$35.7K
COMPANIES
1
ACTIVE SINCE
Apr 2020
HOLDINGS NOW
14,100
AVG SELL PX
TRADE KIND
SHOWING 7 / 7
Trades · vs SPY
Loading price series…
Performance · forward returns vs SPY
1 backtested trades · 8 horizons
Forward-return performance of every backtestable P/S trade by Jerry B. Gin, measured at 8 horizons from 7 days to 2 years. Deduped per economic event so co-filings count once. Excess return = trade return minus SPY return over the same window.
HORIZONTRADESWIN RATEINSIDER RETURNSPY RETURNMEAN EXCESSMEDIAN EXCESST-STAT
7d1+0.00%-7.39%-1.96%-5.43%-5.43%
14d1+0.00%-23.86%-7.36%-16.50%-16.50%
30d1+0.00%-14.50%-9.52%-4.98%-4.98%
60d1+0.00%-49.55%-13.92%-35.63%-35.63%
90d1+0.00%-33.80%-7.20%-26.59%-26.59%
180d1+100.00%+1.88%-2.72%+4.60%+4.60%
1y1+0.00%-17.93%+3.68%-21.61%-21.61%
2y1+0.00%-51.06%+33.50%-84.56%-84.56%
How to read this: Insider Returnis the average raw return of the filer's trades over the horizon. SPY Return is what SPY did over those same windows — reference only, not a comparison. The headline alpha number is Mean Excess = Insider − SPY; green means the filer beat SPY, red means they trailed it. Win rate is the share of individual trades where the filer beat SPY. T-statvalues above 2 mean the alpha is unlikely to be chance given the sample size. "Pending" counts trades where the horizon hasn't elapsed yet; their stats are not included in the row average.
Holdings over time
VTGN · 14,100 shares · as of Sep 6, 2024
025,00050,00075,000100,0002021202220232024SHARES HELD
Trading cadence · quarterly flow
BUY SELL
2020
2020
2020
2021
2021
2021
2021
2022
2022
2022
2022
2023
2023
2023
2023
2024
2024
2024
FLOW · 7 buys / 0 sellsCOVERAGE · 18 quarters
Form 4 filings · all activity
COMPANYTYPESHARESPRICEVALUEHELD AFTERTRADE DATEFILEDDETAILS
VTGN
VISTAGEN THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
14,10014,100Sep 6, 2024Sep 10, 2024View →
VTGN
VISTAGEN THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
12,50012,500Mar 4, 2024Mar 6, 2024View →
VTGN
VISTAGEN THERAPEUTICS, INC.
PURCHASE
100,000$0.18$17.9K100,000Aug 18, 2022Aug 22, 2022View →
VTGN
VISTAGEN THERAPEUTICS, INC.
PURCHASE
100,000$0.18$17.9K100,000Aug 18, 2022Aug 22, 2022View →
VTGN
VISTAGEN THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
100,000100,000Mar 1, 2022Mar 3, 2022View →
VTGN
VISTAGEN THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
75,00075,000Dec 30, 2020Jan 4, 2021View →
VTGN
VISTAGEN THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
75,00075,000Apr 23, 2020Apr 27, 2020View →
Other insiders · VTGN
Loading peer insiders…
About this filer
CIK 0000901014
ROLE
Director
PRIMARY
VTGN
COMPANIES
1
ACTIVE SINCE
Apr 2020
MARKETPEEL · /INSIDER/0000901014DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE
FREE · DAILY · 6 AM ET

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback